These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 32921631)

  • 1. Emerging roles of the MAGE protein family in stress response pathways.
    Florke Gee RR; Chen H; Lee AK; Daly CA; Wilander BA; Fon Tacer K; Potts PR
    J Biol Chem; 2020 Nov; 295(47):16121-16155. PubMed ID: 32921631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.
    Lee AK; Potts PR
    J Mol Biol; 2017 Apr; 429(8):1114-1142. PubMed ID: 28300603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of MAGE-A3/6 by the CRL4-DCAF12 ubiquitin ligase and nutrient availability.
    Ravichandran R; Kodali K; Peng J; Potts PR
    EMBO Rep; 2019 Jul; 20(7):e47352. PubMed ID: 31267705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases.
    Yang SW; Huang X; Lin W; Min J; Miller DJ; Mayasundari A; Rodrigues P; Griffith EC; Gee CT; Li L; Li W; Lee RE; Rankovic Z; Chen T; Potts PR
    Nat Commun; 2020 Oct; 11(1):4931. PubMed ID: 33004795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.
    Doyle JM; Gao J; Wang J; Yang M; Potts PR
    Mol Cell; 2010 Sep; 39(6):963-74. PubMed ID: 20864041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MAGE protein family and cancer.
    Weon JL; Potts PR
    Curr Opin Cell Biol; 2015 Dec; 37():1-8. PubMed ID: 26342994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGE proteins regulate KRAB zinc finger transcription factors and KAP1 E3 ligase activity.
    Xiao TZ; Suh Y; Longley BJ
    Arch Biochem Biophys; 2014 Dec; 563():136-44. PubMed ID: 25107531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.
    Gao Y; Mutter-Rottmayer E; Greenwalt AM; Goldfarb D; Yan F; Yang Y; Martinez-Chacin RC; Pearce KH; Tateishi S; Major MB; Vaziri C
    Nat Commun; 2016 Jul; 7():12105. PubMed ID: 27377895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs.
    Lian Y; Meng L; Ding P; Sang M
    Clin Epigenetics; 2018 Sep; 10(1):115. PubMed ID: 30185218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex.
    Kozakova L; Vondrova L; Stejskal K; Charalabous P; Kolesar P; Lehmann AR; Uldrijan S; Sanderson CM; Zdrahal Z; Palecek JJ
    Cell Cycle; 2015; 14(6):920-30. PubMed ID: 25590999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
    Nardiello T; Jungbluth AA; Mei A; Diliberto M; Huang X; Dabrowski A; Andrade VC; Wasserstrum R; Ely S; Niesvizky R; Pearse R; Coleman M; Jayabalan DS; Bhardwaj N; Old LJ; Chen-Kiang S; Cho HJ
    Clin Cancer Res; 2011 Jul; 17(13):4309-19. PubMed ID: 21565982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAGE cancer-testis antigens protect the mammalian germline under environmental stress.
    Fon Tacer K; Montoya MC; Oatley MJ; Lord T; Oatley JM; Klein J; Ravichandran R; Tillman H; Kim M; Connelly JP; Pruett-Miller SM; Bookout AL; Binshtock E; Kamiński MM; Potts PR
    Sci Adv; 2019 May; 5(5):eaav4832. PubMed ID: 31149633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic activity and cellular functionality of melanoma associated antigen A3.
    Schäfer P; Paraschiakos T; Windhorst S
    Biochem Pharmacol; 2021 Oct; 192():114700. PubMed ID: 34303709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When MAGE meets RING: insights into biological functions of MAGE proteins.
    Feng Y; Gao J; Yang M
    Protein Cell; 2011 Jan; 2(1):7-12. PubMed ID: 21337005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of AMPK by a cancer-specific ubiquitin ligase.
    Pineda CT; Ramanathan S; Fon Tacer K; Weon JL; Potts MB; Ou YH; White MA; Potts PR
    Cell; 2015 Feb; 160(4):715-728. PubMed ID: 25679763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4.
    Marcar L; Ihrig B; Hourihan J; Bray SE; Quinlan PR; Jordan LB; Thompson AM; Hupp TR; Meek DW
    PLoS One; 2015; 10(5):e0127713. PubMed ID: 26001071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E.
    Hao J; Song X; Wang J; Guo C; Li Y; Li B; Zhang Y; Yin Y
    Oncotarget; 2015 Dec; 6(39):42028-39. PubMed ID: 26540345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGED1: molecular insights and clinical implications.
    Wang X; Gao X; Xu Y
    Ann Med; 2011 Aug; 43(5):347-55. PubMed ID: 21612333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK.
    Shaw RJ
    Curr Biol; 2015 May; 25(10):R418-20. PubMed ID: 25989082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.